Literature DB >> 8564261

Induction of nitric oxide synthase and microvascular injury in the rat jejunum provoked by indomethacin.

B J Whittle1, F László, S M Evans, S Moncada.   

Abstract

1. The role of nitric oxide (NO) formed by the inducible isoform of NO synthase (NOS) in the generation of indomethacin-induced intestinal microvascular leakage was investigated in the rat. 2. Indomethacin (10 mg kg-1, s.c.) provoked an elevation of vascular leakage of radiolabelled human serum albumin in the jejunum over 48 h, commencing 18 h after its administration. This was associated with the induction of a calcium-independent NOS, as assessed by the conversion of radiolabelled L-arginine to citrulline. 3. Pretreatment with the glucocorticoid, dexamethasone (1 mg kg-1 day-1, s.c.) inhibited the induction of NOS and reduced jejunal microvascular leakage, determined 24 and 48 h after indomethacin. 4. Administration of the broad-spectrum antibiotic, ampicillin (800 mg kg-1 day-1, p.o.) likewise inhibited both the induction of NOS and the plasma leakage observed 24 and 48 h after indomethacin. 5. Ampicillin pretreatment did not, however, inhibit the induction of NOS, determined 5 h following endotoxin (3 mg kg-1 i.v.) challenge. Furthermore, incubation with ampicillin (1 mM, 10 min) did not inhibit the activity of the calcium-independent isoform in vitro. 6. Administration of the NOS inhibitor, NG-nitro-L-arginine methyl ester (L-NAME, 2-10 mg kg-1, s.c.), at the time of the detectable expression of the inducible NOS (18 h after indomethacin), dose-dependently attenuated the plasma leakage, determined 6 later. This effect was reversed by pretreatment with L-arginine (300 mg kg-1, s.c.) 15 min before L-NAME. 7. These findings suggest that induction of a calcium-independent NOS following indomethacin administration involves gut bacteria and leads to microvascular injury in the rat jejunum.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8564261      PMCID: PMC1908985          DOI: 10.1111/j.1476-5381.1995.tb15066.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

1.  The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat.

Authors:  N K Boughton-Smith; S M Evans; F Laszlo; B J Whittle; S Moncada
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

2.  Indomethacin-induced intestinal inflammation.

Authors:  W F Fang; A Broughton; E D Jacobson
Journal:  Am J Dig Dis       Date:  1977-09

3.  Jejunal ulcers produced by indomethacin.

Authors:  A Somogyi; K Kovács; H Selye
Journal:  J Pharm Pharmacol       Date:  1969-02       Impact factor: 3.765

4.  Nitric oxide synthase activity in ulcerative colitis and Crohn's disease.

Authors:  N K Boughton-Smith; S M Evans; C J Hawkey; A T Cole; M Balsitis; B J Whittle; S Moncada
Journal:  Lancet       Date:  1993-08-07       Impact factor: 79.321

5.  Immunohistochemical localization of an inducible form of nitric oxide synthase in various organs of rats treated with Propionibacterium acnes and lipopolysaccharide.

Authors:  T Bandaletova; I Brouet; H Bartsch; T Sugimura; H Esumi; H Ohshima
Journal:  APMIS       Date:  1993-04       Impact factor: 3.205

6.  Mucosal injury and inflammation in a model of chronic granulomatous colitis in rats.

Authors:  T Yamada; R B Sartor; S Marshall; R D Specian; M B Grisham
Journal:  Gastroenterology       Date:  1993-03       Impact factor: 22.682

7.  Nitric oxide synthase induction and intestinal epithelial cell viability in rats.

Authors:  B L Tepperman; J F Brown; B J Whittle
Journal:  Am J Physiol       Date:  1993-08

8.  Resistance of germfree rats to indomethacin-induced intestinal lesions.

Authors:  A Robert; T Asano
Journal:  Prostaglandins       Date:  1977-08

9.  Nitric oxide release in response to gut injury.

Authors:  M J Miller; X J Zhang; H Sadowska-Krowicka; S Chotinaruemol; J A McIntyre; D A Clark; S A Bustamante
Journal:  Scand J Gastroenterol       Date:  1993-02       Impact factor: 2.423

10.  Mechanisms of acute and chronic intestinal inflammation induced by indomethacin.

Authors:  T Yamada; E Deitch; R D Specian; M A Perry; R B Sartor; M B Grisham
Journal:  Inflammation       Date:  1993-12       Impact factor: 4.092

View more
  29 in total

1.  COX-1 and COX-2 products in the gut: therapeutic impact of COX-2 inhibitors.

Authors:  B J Whittle
Journal:  Gut       Date:  2000-09       Impact factor: 23.059

2.  Role of endogenous and exogenous nitric oxide on intestinal mucosa and microflora in the rat.

Authors:  L Cuzzolin; A Adami; F Crivellente; G Benoni
Journal:  Inflammation       Date:  1997-08       Impact factor: 4.092

3.  New dogmas or old?

Authors:  B J R Whittle
Journal:  Gut       Date:  2003-09       Impact factor: 23.059

4.  Factors involved in upregulation of inducible nitric oxide synthase in rat small intestine following administration of nonsteroidal anti-inflammatory drugs.

Authors:  Koji Takeuchi; Aya Yokota; Akiko Tanaka; Yuka Takahira
Journal:  Dig Dis Sci       Date:  2006-07       Impact factor: 3.199

Review 5.  Present status and strategy of NSAIDs-induced small bowel injury.

Authors:  Kazuhide Higuchi; Eiji Umegaki; Toshio Watanabe; Yukiko Yoda; Eijiro Morita; Mitsuyuki Murano; Satoshi Tokioka; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2009-07-01       Impact factor: 7.527

6.  CV-11974, angiotensin II type I receptor antagonist, reduces the severity of indomethacin-induced rat enteritis.

Authors:  Toshimitsu Okuda; Norimasa Yoshida; Tomohisa Takagi; Osamu Handa; Satoshi Kokura; Hiroshi Ichikawa; Yuji Naito; Toshikazu Yoshikawa
Journal:  Dig Dis Sci       Date:  2007-09-01       Impact factor: 3.199

7.  Stress increases susceptibility to oxidative/nitrosative mucosal damage in an experimental model of colitis in rats.

Authors:  Arturo L Colón; José L M Madrigal; Luis A Menchén; María A Moro; Ignacio Lizasoain; Pedro Lorenzo; Juan C Leza
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

8.  Mast cells are involved in the pathogenesis of indomethacin-induced rat enteritis.

Authors:  Tetsuya Okayama; Norimasa Yoshida; Kazuhiko Uchiyama; Tomohisa Takagi; Hiroshi Ichikawa; Toshikazu Yoshikawa
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

9.  In vitro and in vivo protection against indomethacin-induced small intestinal injury by proton pump inhibitors, acid pump antagonists, or indomethacin-phosphatidylcholine.

Authors:  Yun Jeong Lim; Tri M Phan; Elizabeth J Dial; David Y Graham; Lenard M Lichtenberger
Journal:  Digestion       Date:  2012-08-14       Impact factor: 3.216

10.  Prevention of NSAID-Induced Small Intestinal Mucosal Injury: Prophylactic Potential of Lansoprazole.

Authors:  Kazuhide Higuchi; Yukiko Yoda; Kikuko Amagase; Shinichi Kato; Satoshi Tokioka; Mitsuyuki Murano; Koji Takeuchi; Eiji Umegaki
Journal:  J Clin Biochem Nutr       Date:  2009-08-28       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.